Applied Therapeutics Inc.

2.11+0.0900+4.46%Vol 377.54K1Y Perf 80.36%
Nov 30th, 2023 16:00 DELAYED
BID2.00 ASK2.33
Open1.97 Previous Close2.02
Pre-Market- After-Market2.07
 - -  -0.04 -1.90%
Target Price
12.63 
Analyst Rating
Strong Buy 1.00
Potential %
498.58 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/50/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-100/98/30 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/97/80 
Income Ranking
 —    -
Price Range Ratio 52W %
58.51 
Earnings Rating
Neutral
Market Cap162.95M 
Earnings Date
8th Nov 2023
Alpha0.01 Standard Deviation0.34
Beta1.56 

Today's Price Range

1.962.20

52W Range

0.70003.11

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
14.05%
1 Month
-9.05%
3 Months
61.07%
6 Months
62.31%
1 Year
80.36%
3 Years
-89.88%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
APLT2.110.09004.46
AAPL189.910.54000.29
GOOG133.91-2.4900-1.83
MSFT378.73-0.1200-0.03
XOM102.740.40000.39
WFC44.590.81001.85
JNJ154.662.55001.68
FB196.640.99000.51
GE121.802.94002.47
JPM156.081.76001.14
Financial StrengthValueIndustryS&P 500US Markets
1.00
1.20
0.05
0.27
-
Leverage Ratio 2.60
ProfitabilityValueIndustryS&P 500US Markets
-
-
-
-
-
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023--0.37-
Q01 2023--0.18-
Q04 2022--0.16-
Q03 2022-0.45-0.4011.11
Q02 2022--0.80-
Q01 2022-0.82-0.88-7.32
Q04 2021-1.22-1.0414.75
Q03 2021-0.99-1.09-10.10
Earnings Per EndEstimateRevision %Trend
9/2022 QR-0.4084.13Positive
12/2022 QR-0.4083.87Positive
12/2022 FY-2.34-37.65Negative
12/2023 FY-1.25--
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume377.54K
Shares Outstanding77.23K
Shares Float62.48M
Trades Count2.93K
Dollar Volume784.76K
Avg. Volume659.26K
Avg. Weekly Volume413.64K
Avg. Monthly Volume551.50K
Avg. Quarterly Volume1.01M

Applied Therapeutics Inc. (NASDAQ: APLT) stock closed at 2.11 per share at the end of the most recent trading day (a 4.46% change compared to the prior day closing price) with a volume of 377.54K shares and market capitalization of 162.95M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 22 people. Applied Therapeutics Inc. CEO is Shoshana Shendelman.

The one-year performance of Applied Therapeutics Inc. stock is 80.36%, while year-to-date (YTD) performance is 177.63%. APLT stock has a five-year performance of %. Its 52-week range is between 0.7 and 3.11, which gives APLT stock a 52-week price range ratio of 58.51%

Applied Therapeutics Inc. currently has a PE ratio of -0.30, a price-to-book (PB) ratio of 4.47, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -121.24%, a ROC of -186.19% and a ROE of -229.28%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Applied Therapeutics Inc., there were 1 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Applied Therapeutics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Applied Therapeutics Inc. is Strong Buy (1), with a target price of $12.63, which is +498.58% compared to the current price. The earnings rating for Applied Therapeutics Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Applied Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Applied Therapeutics Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.93, ATR14 : 0.22, CCI20 : -5.87, Chaikin Money Flow : -0.05, MACD : -0.10, Money Flow Index : 20.10, ROC : 3.94, RSI : 49.04, STOCH (14,3) : 57.14, STOCH RSI : 1.00, UO : 45.73, Williams %R : -42.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Applied Therapeutics Inc. in the last 12-months were: Hansard Adam (Sold 14 215 shares of value $30 334 ), Joel M. Marcus (Option Excercise at a value of $12 994), Perfetti Riccardo (Sold 16 985 shares of value $35 025 ), Real Estate Equities Inc Alexandria (Sold 575 000 shares of value $1 353 425 ), Shoshana Shendelman (Sold 131 502 shares of value $326 648 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.

CEO: Shoshana Shendelman

Telephone: +1 212 220-9226

Address: 545 Fifth Avenue, New York 10173, NY, US

Number of employees: 22

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

55%45%

Bearish Bullish

58%42%

 

News

Stocktwits